Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data

PaperCitations, authors & open-access status

Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 7 citations, 2018 year and gold oa status.

7
Citations
2018
Year
gold
OA Status

Related on ScholarIQ

Elena Garal‐Pantaler
Author
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Economic and Financial Impacts of Cancer
Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
470M+ articles · free account